Ravagalimab

A4DAB219 | Phase-II
TNFRSF5/CD40
G1 / None
AbbVie
Phase-II
Whole mAb
ABBV 323 ABBV-323 ABBV 323 PR 1629977 PR-1629977 PR1629977
—
Avg A4D Score
-0.7183
Score Range
-0.76 to -0.65
Structures
8
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB219_6pe8_H_L 6pe8 100% -0.7592 6.5 4.0 -0.5692 -0.7837
A4DAB219_6pe9_C_D 6pe9 98% -0.7212 6.5 4.0 -0.3934 -0.7631
A4DAB219_6pe9_A_B 6pe9 98% -0.7309 6.5 4.0 -0.4146 -0.7714
A4DAB219_6pe7_H_L 6pe7 100% -0.7516 6.5 4.0 -0.5856 -0.7731
A4DAB219_6pe8_A_B 6pe8 100% -0.6987 6.5 4.0 -0.5599 -0.7165
A4DAB219_6pe9_K_M 6pe9 98% -0.6513 7.0 4.0 -0.3616 -0.7302
A4DAB219_6pe9_H_L 6pe9 98% -0.7177 6.5 4.0 -0.3461 -0.765
A4DAB219_6pe9_E_F 6pe9 98% -0.7158 6.5 4.0 -0.3788 -0.7592